Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,639.00
+44.70 (2.80%)
Oct 1, 2025, 3:29 PM IST
Sun Pharmaceutical Industries Employees
Sun Pharmaceutical Industries had 43,000 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
43,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
12.51M INR
Profits / Employee
2.41M INR
Market Cap
3,925.79B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 43,000 | 0 | - |
Mar 31, 2024 | 43,000 | 2,000 | 4.88% |
Mar 31, 2023 | 41,000 | 3,000 | 7.89% |
Mar 31, 2022 | 38,000 | 1,000 | 2.70% |
Mar 31, 2021 | 37,000 | 1,000 | 2.78% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Divi's Laboratories | 10,542 |
Cipla | 30,313 |
Apollo Hospitals Enterprise | 42,497 |
Mankind Pharma | 26,978 |
Zydus Lifesciences | 27,917 |
Fortis Healthcare | 12,237 |
Alkem Laboratories | 18,785 |
Aurobindo Pharma | 27,707 |
Sun Pharmaceutical Industries News
- 1 day ago - Sun Pharma shares rally nearly 3% as Citi reiterates ‘Buy’ rating, says pricing overhangs now resolved after Pfizer deal - Business Upturn
- 1 day ago - [Brokerage Calls] Stocks to watch on October 1: Ultratech Cement, Muthoot Finance, Manappuram Finance, Amber, Syrma SGS, Sun Pharma and more - Business Upturn
- 1 day ago - Citi bullish on Sun Pharma shares, says MFN and pricing overhangs now resolved after Pfizer deal - Business Upturn
- 1 day ago - Stock Market Live Updates Today, October 1: Adani Enterprises, Power Grid, Adani Green, L&T Technology in focus - Business Upturn
- 1 day ago - Top stocks to watch today, October 1: Adani Enterprises, Sun Pharma, L&T Technology, Adani Green and more - Business Upturn
- 5 days ago - Trump's 100% tariffs on branded drugs: Indian generics spared but poses risks for pharma sector – Explained - The Times of India
- 6 days ago - Not a med emergency: Generic pharma cos spared from harm - The Times of India
- 6 days ago - Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in - The Times of India